{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:00:35Z","timestamp":1790082035297,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04399-9","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:36:02Z","timestamp":1782909362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From heterogeneity to mechanism: a systems-level analysis pinpoints the S100A8\/A9 axis in colorectal cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-4180","authenticated-orcid":false,"given":"Hamideh","family":"Raeisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Saeedi Niasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Nazemalhosseini Mojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiseh","family":"Erfanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binazir","family":"Khanabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Saghafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Safarpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"3","key":"4399_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4399_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"issue":"4","key":"4399_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","volume":"66","author":"M Arnold","year":"2017","unstructured":"Arnold M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683\u201391.","journal-title":"Gut"},{"issue":"3","key":"4399_CR4","doi-asserted-by":"publisher","first-page":"e00317","DOI":"10.14309\/ctg.0000000000000317","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Smoking, Genetic Predisposition, and Colorectal Cancer Risk. Clin Transl Gastroenterol. 2021;12(3):e00317.","journal-title":"Clin Transl Gastroenterol"},{"issue":"1","key":"4399_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12902-019-0444-6","volume":"19","author":"G Soltani","year":"2019","unstructured":"Soltani G, et al. Obesity, diabetes and the risk of colorectal adenoma and cancer. BMC Endocr Disorders. 2019;19(1):113.","journal-title":"BMC Endocr Disorders"},{"key":"4399_CR6","doi-asserted-by":"crossref","unstructured":"Okugawa, Y., W.M. Grady, and A. Goel, Epigenetic Alterations in Colorectal Cancer: Emerging\u00a0Biomarkers. Gastroenterology, 2015. 149(5): pp. 1204\u20131225.e12.","DOI":"10.1053\/j.gastro.2015.07.011"},{"key":"4399_CR7","doi-asserted-by":"publisher","unstructured":"Allg\u00f6wer C et al. Friend or Foe: S100 Proteins in Cancer. Cancers (Basel), 2020. 12(8):2037. https:\/\/doi.org\/10.3390\/cancers12082037","DOI":"10.3390\/cancers12082037"},{"issue":"8","key":"4399_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/ijms.8128","volume":"11","author":"H Wang","year":"2014","unstructured":"Wang H, et al. Activation of the PI3K\/Akt\/mTOR\/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells. Int J Med Sci. 2014;11(8):841\u20139.","journal-title":"Int J Med Sci"},{"issue":"4","key":"4399_CR9","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3892\/or.2013.2236","volume":"29","author":"Y Zhao","year":"2013","unstructured":"Zhao Y, Zhang TB, Wang Q. Clinical significance of altered S100A2 expression in gastric cancer. Oncol Rep. 2013;29(4):1556\u201362.","journal-title":"Oncol Rep"},{"issue":"1","key":"4399_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.21873\/invivo.11777","volume":"34","author":"A Diamantopoulou","year":"2020","unstructured":"Diamantopoulou A, et al. A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer. Vivo. 2020;34(1):321\u201330.","journal-title":"Vivo"},{"issue":"5","key":"4399_CR11","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1007\/s13277-015-4460-5","volume":"37","author":"D Li","year":"2016","unstructured":"Li D, et al. Expression and clinical implication of S100A12 in gastric carcinoma. Tumour Biol. 2016;37(5):6551\u20139.","journal-title":"Tumour Biol"},{"issue":"31","key":"4399_CR12","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.18632\/oncotarget.26861","volume":"10","author":"S Basnet","year":"2019","unstructured":"Basnet S, et al. Expression profile and functional role of S100A14 in human cancer. Oncotarget. 2019;10(31):2996\u20133012.","journal-title":"Oncotarget"},{"issue":"1","key":"4399_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-022-09180-5","volume":"22","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, et al. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma. BMC Cancer. 2022;22(1):77.","journal-title":"BMC Cancer"},{"issue":"12","key":"4399_CR14","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1007\/s13277-014-2573-x","volume":"35","author":"X Xuan","year":"2014","unstructured":"Xuan X, et al. Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer. Tumour Biol. 2014;35(12):12535\u201343.","journal-title":"Tumour Biol"},{"issue":"21","key":"4399_CR15","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-05-0714","volume":"11","author":"K Ohuchida","year":"2005","unstructured":"Ohuchida K, et al. The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res. 2005;11(21):7785\u201393.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"4399_CR16","doi-asserted-by":"publisher","first-page":"e62092","DOI":"10.1371\/journal.pone.0062092","volume":"8","author":"L Duan","year":"2013","unstructured":"Duan L, et al. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt\/\u03b2-catenin pathway. PLoS ONE. 2013;8(4):e62092.","journal-title":"PLoS ONE"},{"key":"4399_CR17","doi-asserted-by":"publisher","unstructured":"Singh P, Ali SA. Multifunctional Role of S100 Protein Family in the Immune System: An Update. Cells, 2022. 11(15):2274. https:\/\/doi.org\/10.3390\/cells11152274","DOI":"10.3390\/cells11152274"},{"issue":"6","key":"4399_CR18","doi-asserted-by":"publisher","first-page":"118677","DOI":"10.1016\/j.bbamcr.2020.118677","volume":"1867","author":"LL Gonzalez","year":"2020","unstructured":"Gonzalez LL, Garrie K, Turner MD. Role of S100 proteins in health and disease. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2020;1867(6):118677.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"2","key":"4399_CR19","first-page":"89","volume":"4","author":"H Chen","year":"2014","unstructured":"Chen H, et al. S100 protein family in human cancer. Am J Cancer Res. 2014;4(2):89\u2013115.","journal-title":"Am J Cancer Res"},{"key":"4399_CR20","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1017\/erm.2025.10019","volume":"27","author":"H Raeisi","year":"2025","unstructured":"Raeisi H, et al. Role of S100 family proteins in colorectal cancer (CRC): an overview of their potential function as new biomarkers and therapeutic agents. Expert Rev Mol Med. 2025;27:e31.","journal-title":"Expert Rev Mol Med"},{"issue":"9","key":"4399_CR21","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/s43018-024-00807-z","volume":"5","author":"X Chu","year":"2024","unstructured":"Chu X, et al. Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms. Nat Cancer. 2024;5(9):1409\u201326.","journal-title":"Nat Cancer"},{"issue":"7875","key":"4399_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41586-021-03852-1","volume":"597","author":"R Elmentaite","year":"2021","unstructured":"Elmentaite R, et al. Cells of the human intestinal tract mapped across space and time. Nature. 2021;597(7875):250\u20135.","journal-title":"Nature"},{"issue":"1","key":"4399_CR23","doi-asserted-by":"publisher","first-page":"12618","DOI":"10.1038\/s41598-025-96211-3","volume":"15","author":"H Raeisi","year":"2025","unstructured":"Raeisi H, et al. Development of novel neutralizing single-chain fragment variable antibodies against S100A8. Sci Rep. 2025;15(1):12618.","journal-title":"Sci Rep"},{"issue":"2","key":"4399_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15(2):96\u2013109.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"4399_CR25","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.febslet.2015.07.010","volume":"589","author":"ME Mercado-Pimentel","year":"2015","unstructured":"Mercado-Pimentel ME, et al. The S100P\/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS Lett. 2015;589(18):2388\u201393.","journal-title":"FEBS Lett"},{"issue":"4","key":"4399_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cancergen.2016.02.002","volume":"209","author":"Z-Y Shen","year":"2016","unstructured":"Shen Z-Y, et al. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma. Cancer Genet. 2016;209(4):143\u201353.","journal-title":"Cancer Genet"},{"key":"4399_CR27","doi-asserted-by":"publisher","unstructured":"Chen Y et al. S100A8 and S100A9 in Cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2023. 1878(3): p. 188891. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188891","DOI":"10.1016\/j.bbcan.2023.188891"},{"key":"4399_CR28","doi-asserted-by":"crossref","unstructured":"Palomo-Irigoyen M, et al. Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes. Cell Death & Differentiation; 2025. pp. 1\u201312.","DOI":"10.1093\/jimmun\/vkaf283.2371"},{"issue":"11","key":"4399_CR29","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1080\/00365520701416709","volume":"42","author":"ST Leach","year":"2007","unstructured":"Leach ST, et al. Serum and mucosal S100 proteins, calprotectin (S100A8\/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42(11):1321\u201331.","journal-title":"Scand J Gastroenterol"},{"key":"4399_CR30","doi-asserted-by":"publisher","first-page":"896645","DOI":"10.3389\/fimmu.2022.896645","volume":"13","author":"Z Yao","year":"2022","unstructured":"Yao Z, et al. Neutrophil infiltration characterized by upregulation of S100A8, S100A9, S100A12 and CXCR2 is associated with the co-occurrence of Crohn\u2019s disease and peripheral artery disease. Front Immunol. 2022;13:896645.","journal-title":"Front Immunol"},{"issue":"1","key":"4399_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12014-022-09364-y","volume":"19","author":"MJ Munro","year":"2022","unstructured":"Munro MJ, et al. Proteomic analysis of low-and high-grade human colon adenocarcinoma tissues and tissue-derived primary cell lines reveals unique biological functions of tumours and new protein biomarker candidates. Clin Proteomics. 2022;19(1):27.","journal-title":"Clin Proteomics"},{"issue":"2","key":"4399_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1365-2567.2012.03566.x","volume":"136","author":"F Zhao","year":"2012","unstructured":"Zhao F, et al. S100A9 a new marker for monocytic human myeloid-derived suppressor cells. Immunology. 2012;136(2):176\u201383.","journal-title":"Immunology"},{"issue":"4","key":"4399_CR33","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179(4):829\u2013e84520.","journal-title":"Cell"},{"issue":"4","key":"4399_CR34","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.xcrm.2023.100987","volume":"4","author":"X Bao","year":"2023","unstructured":"Bao X, et al. An immunometabolism subtyping system identifies S100A9(+) macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis. Cell Rep Med. 2023;4(4):100987.","journal-title":"Cell Rep Med"},{"issue":"7","key":"4399_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/1759-7714.12649","volume":"9","author":"H Huang","year":"2018","unstructured":"Huang H, et al. Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer. Thorac Cancer. 2018;9(7):800\u20134.","journal-title":"Thorac Cancer"},{"key":"4399_CR36","doi-asserted-by":"publisher","unstructured":"Deguchi A et al. Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway. Cancer Gene Ther, 2023: Jul;30(7):973-984.. https:\/\/doi.org\/10.1038\/s41417-023-00604-3","DOI":"10.1038\/s41417-023-00604-3"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04399-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:10Z","timestamp":1790078590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4399"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04399-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Institutional Ethical Review Committee of the Research Institute for Gastroenterology and Liver Diseases at Shahid Beheshti University of Medical Sciences (Ethics Code: IR.SBMU.RIGLD.REC.1404.054). All pathological tissue samples used in this study were prospectively collected from subjects referred for colonoscopy at Taleghani Hospital in Tehran, Iran. All participants provided written informed consent prior to inclusion. Access to personal data was strictly limited to authorized personnel in a manner that protects individual privacy. The authors declare no competing interests related to the publication of this study, and all funding sources have been disclosed.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"321"}}